)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
Agenus
Agenus (AGEN) investor relations material
Agenus AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.AGM 2026 summary31 Mar, 2026
Opening remarks and agenda
Emphasized the urgent need to expand immunotherapy to patients with historically unresponsive cancers, especially MSS colorectal cancer, and outlined the session's focus on clinical progress, patient access, and operational readiness.
Highlighted the convergence of clinical development, patient access, and operational readiness as key themes for the meeting.
Financial performance review
Reported $3.2 million in realized revenues in Q4 from the French AAC and named patient programs, reflecting growing physician and patient demand.
Noted increasing interest and inquiries from over 30 countries, with 270 requests by end of March, indicating expanding global reach.
Board and executive committee updates
Leadership discussed the company's mission, regulatory strategy, and operational priorities, with active participation from the CEO, CMO, and CCO.
Announced the formalization of a medical education and medical affairs department to support physician education and real-world data collection.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Agenus
- BOT + BAL enters Phase 3 with $4.2M early access revenue and $91M Zydus capital boost.AGEN
Q4 202516 Mar 2026 - Zydus partnership secures manufacturing and capital, driving global access and pivotal trials for BOT/BAL.AGENStatus update3 Feb 2026
- BOT/BAL data strong, cash up, but partnership losses and going concern risks persist.AGENQ2 20242 Feb 2026
- BOT/BAL shows robust efficacy in colorectal cancer, with pivotal trials and regulatory milestones ahead.AGENWells Fargo 2024 Healthcare Conference22 Jan 2026
- BOT/BAL shows strong efficacy in hard-to-treat cancers, with pivotal data and regulatory steps ahead.AGENH.C. Wainwright 26th Annual Global Investment Conference 202421 Jan 2026
- Unprecedented clinical progress offsets losses, but urgent funding and asset sales are needed.AGENQ3 202415 Jan 2026
- BOT/BAL advances to Phase 3 with strong survival data and $91M Zydus funding secured.AGENQ2 20256 Jan 2026
- Reduced cash burn and BOT/BAL progress drive focus amid tight financials.AGENQ4 202426 Dec 2025
- Biotech registers 165,000 shares for warrant exercise, seeking capital amid ongoing financial risk.AGENRegistration Filing16 Dec 2025
Next Agenus earnings date
Q1 202612 May, 2026
Agenus
Next Agenus earnings date
Q1 202612 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage